Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Queensland Health
US Army
McKesson
Chubb
McKinsey
Argus Health
Cerilliant
Colorcon

Generated: June 23, 2018

DrugPatentWatch Database Preview

KIONEX Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Kionex patents expire, and what generic alternatives are available?

Kionex is a drug marketed by Paddock Llc and is included in two NDAs.

The generic ingredient in KIONEX is sodium polystyrene sulfonate. There are one thousand four hundred and twenty-six drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the sodium polystyrene sulfonate profile page.
Summary for KIONEX
US Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: 1
Formulation / Manufacturing:see details
DailyMed Link:KIONEX at DailyMed
Drug patent expirations by year for KIONEX

US Patents and Regulatory Information for KIONEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Paddock Llc KIONEX sodium polystyrene sulfonate POWDER;ORAL, RECTAL 040029-001 Feb 6, 1998 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Paddock Llc KIONEX sodium polystyrene sulfonate SUSPENSION;ORAL, RECTAL 040028-001 Sep 17, 2007 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Chubb
US Army
Boehringer Ingelheim
McKinsey
Deloitte
Johnson and Johnson
Julphar
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.